Quantitative <sup>31</sup>P-NMR for the Purity Determination of the Organophosphorus Compound Brigatinib and Its Method Validation-Reference-Cited by-同舟云学术

Quantitative <sup>31</sup>P-NMR for the Purity Determination of the Organophosphorus Compound Brigatinib and Its Method Validation

Published:2024-01-01 Issue:1 Volume:72 Page:36-40
ISSN:0009-2363
Container-title:Chemical and Pharmaceutical Bulletin
language:en
Short-container-title:CHEMICAL & PHARMACEUTICAL BULLETIN

Author:

Uchiyama Nahoko¹,Hosoe Junko¹,Komatsu Takanori²,Sugimoto Naoki¹,Ishizuki Kyoko¹,Koide Tatsuo¹,Murabayashi Mika³,Shinozaki Taeko⁴,Kobayashi Kengo⁴,Fujimine Yoshinori⁵,Ofuji Katsuya⁶,Shimizu Hitoshi⁶,Hasebe Takashi⁷,Asai Yumi⁷,Ena Eri⁷,Kiyota Kohei⁸,Fujita Kazuhiro⁸,Makino Yoshinobu⁹,Miura Toru¹⁰,Muto Yasuhiro¹⁰,Asakura Katsuo²,Suematsu Takako²,Muto Hitomi²,Kohama Ai¹¹,Goto Takashi¹²,Yasuda Masu¹²,Ueda Tomohiko¹³,Goda Yukihiro¹

Affiliation:

1. National Institute of Health Sciences (NIHS)

2. JEOL Ltd.

3. Takeda Pharmaceutical Co., Ltd.

4. Daiichi Sankyo Co., Ltd.

5. Otsuka Pharmaceutical Co., Ltd.

6. Chugai Pharmaceutical Co., Ltd.

7. Eisai Co., Ltd.

8. Shionogi & Co., Ltd.

9. Juzen Chemical Corp.

10. FUJIFILM Wako Pure Chemical Corporation

11. Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ)

12. Nippon Shinyaku Co., Ltd.

13. Sumitomo Pharma Co., Ltd.

Publisher

Pharmaceutical Society of Japan

Subject

Drug Discovery,General Chemistry,General Medicine

Link

https://www.jstage.jst.go.jp/article/cpb/72/1/72_c23-00635/_pdf

Reference13 articles.

1. 1) The Ministry of Health, Labour and Welfare, Japan. “The Japanese Pharmacopoeia Eighteen Edition (2021).”: ‹https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000066597.html›, cited 2 September, 2023.

2. 2) Hosoe J., Sugimoto N., Goda Y., Pharmaceutical and Medical Device Regulatory Science, 41, 960–970 (2010).

3. 3) Hosoe J., Sugimoto N., Suematsu T., Yamada Y., Hayakawa M., Katsuhara T., Nishimura H., Goda Y., Pharmaceutical and Medical Device Regulatory Science, 43, 182–193 (2012).

4. 4) Hosoe J., Sugimoto N., Suematsu T., Yamada Y., Miura T., Hayakawa M., Suzuki H., Katsuhara T., Nishimura H., Kikuchi Y., Yamashita T., Goda Y., Pharmaceutical and Medical Device Regulatory Science, 45, 243–250 (2014).

5. 5) Goda Y., Pharmaceutical and Medical Device Regulatory Science, 48, 615–619 (2017).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Absolute purity determination of an organic fluorine pharmaceutical voriconazole via quantitative 19F NMR and method validation;Journal of Pharmaceutical and Biomedical Analysis Open;2024-12

2. Purity Assessment of Tripropyl Phosphate through Mass Balance and 1H and 31P Quantitative Nuclear Magnetic Resonance;Molecules;2024-04-25